Vela Diagnostics Enters the IVD Market

Informations

• Publié par: vela-diagnostics
• Nombre de lectures: 26
• Langue: English

Extrait

Vela Diagnostics Enters the IVD Market

PR Newswire

SINGAPORE, June 18, 2012

SINGAPORE

,

June 18, 2012

/PRNewswire/ --

Vela Diagnostics has been unveiled as a new global player in the IVD world.

The

Singapore

headquartered Group, which already opened sites in

New Jersey

and

Hamburg

, has announced that its menu of workflow systems and test kits

will be launched progressively from Q3 2012.

"VelaDx stands for a broad and nimble menu of products in Molecular PCR

based Diagnostics," said the Group's CEO Michael Tillmann. "Our automated

workflow will enable hospitals and labs to handle a broader range of tests on a

single platform. Lab professionals will be able to do more, faster but with less

complexity and higher efficiency."

The Company will provide an integrated automated RNA/DNA extraction and

detection workflow on Vela's own "Sentosa" workflow. VelaDx tests will offer

more than 30 test grouped in panels covering Microbiology, Oncology and

Infectious Diseases.

The test kits are successfully transitioning into Production and QC testing, and

will be ready for commercialization in selected Asian and European markets

from Q3 2012. The Company is also seeking regulatory approval in the US and

other markets.

About Vela Diagnostics

VelaDx provides a broad menu of molecular diagnostic tests, consolidated on

its automated "Sentosa" workflow system. The Group was incorporated by an

industry experienced management team in 2011 with the vision of providing

in-

vitro

diagnostic solutions for customers to achieve improved patient

management. VelaDx is a privately owned Group of Companies headquartered

in

Singapore

. The Asia Pacific, European and North American commercial

operations of the Group are based in

Singapore

,

Hamburg

and

New Jersey

,

respectively. VelaDx also operates R&D sites in

Singapore

and

New Jersey

in

addition to a Global Manufacturing facility in

Singapore

. For more information,

please visit us at http://www.veladx.com

Dr. Peter Matthiesen

Director Marketing

Vela Diagnostics Germany GmbH

email: [e-mail]

Telefon: [phone]